NextCure financials
$4.85−4.63%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — | $22.4M | $6.3M |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | — | $22.4M | $6.3M |
| Gross margin | — | — | — | — | — | 100.0% | 100.0% |
| Operating income | -$57.6M | -$59.7M | -$67.6M | -$75.9M | -$70.8M | -$41.2M | -$37.5M |
| Net income | -$55.8M | -$55.7M | -$62.7M | -$74.7M | -$69.4M | -$36.6M | -$33.7M |
| Net margin | — | — | — | — | — | −163.6% | −531.5% |
| Diluted EPS | $-19.65 | $-23.88 | $-27.00 | $-32.28 | $-30.12 | $-15.96 | $-25.80 |
| EBITDA | -$55.4M | -$54.3M | -$64.0M | -$71.8M | -$66.6M | -$37.8M | -$34.8M |
| Operating cash flow | -$49.6M | -$40.8M | -$53.0M | -$53.9M | -$57.3M | -$45.0M | -$35.6M |
| Free cash flow | -$49.6M | -$41.3M | -$53.8M | -$56.0M | -$59.6M | -$52.1M | -$39.0M |
| Diluted shares | 2.8M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 1.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.0M | $27.7M | $13.1M | $26.6M | $12.3M | $32.8M |
| Short-term investments | $15.8M | $40.9M | $95.2M | $133.3M | $207.3M | $250.7M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.5M |
| Total assets | $50.2M | $80.9M | $128.0M | $184.2M | $242.4M | $306.6M |
| Total liabilities | $15.2M | $15.4M | $13.6M | $16.6M | $9.0M | $12.9M |
| Shareholders' equity | $34.9M | $65.5M | $114.4M | $167.5M | $233.4M | $293.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology